Group One Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,052
| Closed | -$1.67K | – | 3366 |
|
|
2024
Q1 | $1.67K | Hold |
1,052
| – | – | ﹤0.01% | 1518 |
|
|
2023
Q4 | $904 | Buy |
1,052
+600
| +133% | +$516 | ﹤0.01% | 1685 |
|
|
2023
Q3 | $484 | Buy |
+452
| New | +$484 | ﹤0.01% | 1751 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3547 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3437 |
|
|
2022
Q4 | – | Sell |
-4,290
| Closed | -$56K | – | 3476 |
|
|
2022
Q3 | $56K | Buy |
+4,290
| New | +$56K | ﹤0.01% | 1196 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3498 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3485 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3487 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3401 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$3K | – | 3249 |
|
|
2021
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 1738 |
|
|
2020
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 1532 |
|
|
2020
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1440 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2444 |
|